KPMG Video Insights information@kpmg.de https://videostream.kpmg.de de-de Visualplatform http://blogs.law.harvard.edu/tech/rss KPMG Video Insights Unser Podcast für Interessierte Banking episodic no https://videostream.kpmg.de/files/rv1.36/sitelogo.gif https://videostream.kpmg.de http://videostream.kpmg.de/trends-and-challenges-for-life <p><p>Life sciences companies have maneuvered quite well through the Covid-19 pandemic. In the new reality it will be relevant, that the companies leverage their increased societal importance to develop innovative drugs at affordable prices and to become more customer-oriented. Thomas Hillek, Head of Life Sciences &amp; Chemicals at KPMG in Germany, explains which four overarching trends influence the new reality of life sciences companies and highlights possible actions.</p></p><p><a href="http://videostream.kpmg.de/trends-and-challenges-for-life"><img src="http://videostream.kpmg.de/60445029/64802367/4a1a6d7c46b2d76b1dd8558b9795d795/standard/download-16-thumbnail.jpg" width="75" height=""/></a></p> http://videostream.kpmg.de/photo/64802367 Tue, 05 Jan 2021 17:38:10 GMT Trends and challenges for life sciences companies in the new reality Life sciences companies have maneuvered quite well through the Covid-19 pandemic. In the new reality it will be relevant, that the companies leverage their increased societal importance to develop innovative drugs at affordable prices and to become more customer-oriented. Thomas Hillek, Head of Life Sciences Chemicals at KPMG in Germany, explains which four overarching trends influence the new reality of life sciences companies and highlights possible actions. Life sciences companies have maneuvered quite well through the Covid-19 pandemic. In the new reality it will be relevant, that the companies leverage their increased societal importance to develop innovative drugs at affordable prices and to... KPMG Video Insights 02:42 <p><p>Life sciences companies have maneuvered quite well through the Covid-19 pandemic. In the new reality it will be relevant, that the companies leverage their increased societal importance to develop innovative drugs at affordable prices and to become more customer-oriented. Thomas Hillek, Head of Life Sciences &amp; Chemicals at KPMG in Germany, explains which four overarching trends influence the new reality of life sciences companies and highlights possible actions.</p></p><p><a href="http://videostream.kpmg.de/trends-and-challenges-for-life"><img src="http://videostream.kpmg.de/60445029/64802367/4a1a6d7c46b2d76b1dd8558b9795d795/standard/download-16-thumbnail.jpg" width="75" height=""/></a></p> agility artificial intelligence collaboration models connected enterprise Covid-19 customer experience digitalization english enterprise models health life science companies life sciences medicine new reality patient patient centricity pharmacenticals R&D research supply chain technology therapy transformation